A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
American Regent, Inc.
Techsomed Medical Technologies LTD
Eureka Therapeutics Inc.
Ethicon, Inc.
LEO Pharma
LEO Pharma
Omega Therapeutics
Pfizer
Pfizer
Ethicon, Inc.
Fusion Pharmaceuticals Inc.
Bristol-Myers Squibb
Imunon
Cellxpert Biotechnology Corp.
Nanobiotix
Nucleix Ltd.
Boston Scientific Corporation
Bayer
Aeon Therapeutics (Shanghai) Co., Ltd.
Daiichi Sankyo
Merck KGaA, Darmstadt, Germany
Celgene
Auron Healthcare GmbH
Auron Healthcare GmbH
Abbott
Pathfinder Therapeutics
Progen Pharmaceuticals
FeRx
Tularik